AMNAMN Healthcare Services, Inc.Healthcare · Medical - Care Facilitiesas of 2026-09-16
Horizon

Issued 2026-09-16 at $34.92 · now $34.92 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, AMN has typically landed between $27.49 and $41.48 — a range of −21.3% to +18.8% from the issuance price $34.92.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($34.92) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where AMN has typically landed a month from the 2026-09-16 close of $34.92 — the range is history, not a prediction.

$27.49worst · -21.3%$41.48best · +18.8%
  • now $34.92 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $34.34 (-1.7%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $31.39$37.3
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $27.49$41.48
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2024-10-17−44.1%−44.1%+0.0%
2008-09-26−43.9%−43.9%+0.0%
2008-10-02−43.8%−43.8%+0.0%
3 best
2026-04-10+69.4%+0.0%+69.4%
2026-04-14+64.4%+0.0%+64.4%
2026-04-13+58.6%+0.0%+62.9%

5,003 overlapping windows · 2006-09-262026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
45%
+1.0%
n=20
Feb
65%
+2.0%
n=20
Mar
40%
−1.1%
n=20
Apr
55%
+2.0%
n=20
May
45%
+1.3%
n=20
Jun
60%
+3.8%
n=20
Jul
55%
+2.7%
n=20
Aug
50%
−0.1%
n=20
Sep
50%
−0.8%
n=20
Oct
50%
−2.5%
n=20
Nov
50%
+1.1%
n=20
Dec
60%
+2.3%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$37$152026-06-15: 2 insider sales, $114K — FOLETTA MARK G …2026-06: 2 open-market sales, $114K↑ buys↓ salesdirector FOLETTA MARK G — Sale on 2026-06-15, filed 2 days after the tradedirector FOLETTA MARK G — Sale on 2026-06-15, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-06-15FOLETTA MARK GdirectorSale2,000 @ $31.07$62K−10.0% of holding+11.1%not yet — horizon still open17,917Form 4 · filed 2 days after the trade
2026-06-15FOLETTA MARK GdirectorSale1,681 @ $31.07$52K−7.8% of holding+11.1%not yet — horizon still open19,917Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

135 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-15Laughlin Whitney MofficerWithheld for tax12224,028Form 4
2026-09-15Laughlin Whitney MofficerOption exercise49824,150Form 4
2026-09-15Laughlin Whitney MofficerOption exercise4980Form 4
2026-05-01FOLETTA MARK GdirectorOption exercise8,3250Form 4
2026-05-01FOLETTA MARK GdirectorAward / grant8,3048,304Form 4
2026-05-01Hinton James H.directorAward / grant8,3048,304Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise5,55572,817Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise4,04876,865Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise6,00982,874Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise8,32567,262Form 4
2026-05-01Caballero Jorge A.directorOption exercise8,32515,462Form 4
2026-05-01Caballero Jorge A.directorOption exercise8,3250Form 4
2026-05-01Caballero Jorge A.directorAward / grant8,3048,304Form 4
2026-05-01FOLETTA MARK GdirectorOption exercise8,32521,598Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise4,0480Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise6,0090Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise9,5630Form 4
2026-05-01Fontenot Teri G.directorAward / grant8,3048,304Form 4
2026-05-01Jones Daphne EdirectorAward / grant8,3048,304Form 4
2026-05-01Palmer Eric PdirectorAward / grant8,3048,304Form 4
2026-05-01Trent-Adams SylviadirectorOption exercise8,32516,797Form 4
2026-05-01Trent-Adams SylviadirectorOption exercise8,3250Form 4
2026-05-01Trent-Adams SylviadirectorAward / grant8,3048,304Form 4
2026-05-01Huber Celia PdirectorAward / grant8,3048,304Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise9,56392,437Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise9,563102,000Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise8,3250Form 4
2026-05-01Jones Daphne EdirectorOption exercise8,3250Form 4
2026-05-01Jones Daphne EdirectorOption exercise8,32517,124Form 4
2026-05-01HARRIS R JEFFREYdirectorOption exercise5,5550Form 4
2026-01-15Grace CarolinedirectorWithheld for tax6,19181,686Form 4
2026-01-15Scott Brian M.officerWithheld for tax3,59213,093Form 4
2026-01-15Grace CarolinedirectorWithheld for tax2,71362,452Form 4
2026-01-15Hagan Mark ChristopherofficerWithheld for tax2,62244,873Form 4
2026-01-15Grace CarolinedirectorWithheld for tax1,49554,501Form 4
2026-01-15Laughlin Whitney MofficerWithheld for tax1,04923,652Form 4
2026-01-15Hagan Mark ChristopherofficerWithheld for tax92640,863Form 4
2026-01-15Hagan Mark ChristopherofficerWithheld for tax59139,541Form 4
2026-01-15Laughlin Whitney MofficerWithheld for tax22321,164Form 4
2026-01-15Laughlin Whitney MofficerWithheld for tax6020,638Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.